22 September 2021 — GMWatch
Discovery of “catastrophic” unintended effect of CRISPR gene editing may have caused slump in companies’ stock. Report: Claire Robinson
CRISPR gene editing is often presented as a straightforward, precise, and safe procedure. But recent research findings on CRISPR gene editing for gene therapy applications show it can lead to massive damage to chromosomes. The phenomenon is known as chromothripsis.